Introduction
vertebrates), Prickle and Celsr1 (flamingo). They were first characterized as regulators of convergent extension, a process during gastrulation and neurulation where lateral cells migrate and intercalate at the midline, thus narrowing and elongating the embryo. Both reduced and increased levels of PCP proteins disturb convergent extension, indicating a dose-dependent effect (CarreiraBarbosa et al., 2003; Darken et al., 2002; Goto and Keller, 2002; Takeuchi et al., 2003; Veeman et al., 2003) . In addition to their role in convergent extension, Vangl2, Celsr1 and Scrb1 also regulate PCP in the mammalian inner ear (Montcouquiol et al., 2006) . Vangl2 is expressed throughout the neural tube. At least part of the role of Strabismus in zebrafish convergent extension is to regulate cell polarity in the neural tube, but it has also been suggested that it facilitates convergent extension movements by regulating cell adhesion (Ciruna et al., 2006) .
We have previously reported that adherens junctions are disrupted in transgenic mouse embryos overexpressing Wnt7a in the developing neural tube (Shariatmadari et al., 2005) . The expression of Vangl2 mRNA was increased in mouse embryos overexpressing Wnt7a, which led us to speculate that the Wnt7a-induced effect is at least partly mediated by Vangl2 and Wnt/PCP signaling. Here, using gain-of-function and loss-of-function approaches in vivo and in vitro, we report that Vangl2 indeed affects the cytoskeleton and cell-cell adhesion. Moreover, we demonstrate that Vangl2 achieves these effects in concert with the small GTPase Rac1 (which binds Vangl2) and relocates to the site of active cytoskeletal remodeling close to the membrane in a Vangl2-dependent way. 
Vang-like protein 2 and Rac1 interact to regulate adherens junctions
Maria
Results

Vangl2 affects cell shape and actin distribution in HEK293T and MDCK cells
In order to study the effect of Vangl2 on cell shape and actin localization in vitro, 80% confluent HEK293T cells were transfected with control plasmid (DsRed) or Vangl2-HA expression plasmid. Transfection rates were high, and only experiments with a transfection rate of more than 80% were analyzed further. Control transfected cells grew in monolayers, where the cells consistently organized themselves in a honeycomb fashion. Labeling F-actin with FITC-phalloidin revealed distinct and continuous cortical (circumferential) actin (Fig. 1A) . Vangl2-HA reduced the areas of the monolayers, and cells appeared to be more loosely attached to each other. Cortical actin was more discontinuous than in control cells, and intracellular actin deposits were observed (Fig. 1B) . Vangl2-HA was present in, or close to, the cell membrane, but was also present to a varying degree in the cytoplasm (Fig. 1BЈ ). Vangl2-HA also yielded a high proportion of single cells or clusters of few, loosely attached cells. The cortical actin in these cells was sparse and highly discontinuous, and intracellular actin deposits were common (Fig. 1C ). The effects of Vangl2 were quantified by three observers. Individual control (n16) or Vangl2 overexpressing (n14) cells were blindly rated. This yielded a number that was higher the more the cell diverted from a hypothetical ideal (see Materials and Methods). On average, control cells were rated 3.4, whereas Vangl2-expressing cells received a rating of 7.2 (Fig. 1D) . The difference was significant (P8.78ϫ10 -9 ). The HEK293T epithelial cell line derives from embryonic kidney, which has been shown to express Vangl2 (Katoh, 2002) . RT-PCR confirmed that HEK293T cells express Vangl2 (Fig. 1E) . To investigate the loss of Vangl2 function in HEK293T cells, we performed RNAi knockdown directed against human Vangl2 (transfection was confirmed with a fluorescent oligo). Vangl2 knockdown caused extensive cell loss during the washes, indicating reduced cell-substrate and cell-cell adherence. The remaining cells were more loosely attached to each other than were control cells, cortical actin was diffuse or discontinuous, and intracellular actin deposits were abundant (Fig. 1F ). In sum, Vangl2 loss-of-function had similar, but more accentuated, effects on cytoskeletal actin, cell morphology and adherence to those of Vangl2 gain-of-function.
We then went on to study MDCK cells, which are more suitable for studies of cell polarity. MDCK cells were transfected with control (DsRed), the Vangl2-HA or the Vangl2-EGFP expression plasmids. HA or EGFP positivity was used as the marker of transfection efficiency. This varied substantially, but only clearly transfected cells were analyzed further. The effects were evaluated 24 or 48 hours post-transfection. Control MDCK cells grew in large monolayers, where the cells often attached to each other in a honeycomb-like fashion. Labeling F-actin with FITC-or TRITC-phalloidin revealed distinct and continuous cortical (circumferential) actin (Fig. 1G ). Vangl2-HA or Vangl2-EGFP transfected cells were irregular in shape, often larger than average, and more elongated (Fig.  1H ,HЈ,I,IЈ). They were frequently distinct both from control transfected and adjacent, untransfected cells. Note the difference in Fig. 1H (untransfected cells marked with arrows) and Fig. 1I (EGFP shown in Fig. 1IЈ ). Actin was irregularly distributed in the cell cortex and cytoplasm (arrowheads in Fig. 1H,I ). Three observers blindly rated how intermittent Vangl2-EGFP overexpressing or control (EGFP) cells differed from adjacent, untransfected cells (high rating  high difference; see Materials and Methods). On average, control transfected cells received a rating of 1.4 and Vangl2-transfected cells 2.7 ( Fig. 1J; P2.4ϫ10 -5 ). We also co-transfected cells with GFP-actin and control (DsRed) or HA-Vangl2 plasmids. GFP fluorescence served a double role as a marker of transfected cells, while visualizing actin. Vangl2-HA effects on GFP-actin were comparable to those on endogenous actin (compare control transfected cells in Fig. 1K with Vangl2-HAtransfected cells in Fig. 1L ).
To test whether the PDZ (post synaptic density protein, Drosophila disc large tumor suppressor and zonula occludens-1 protein)-binding domain was necessary for the ability of Vangl2 to affect the actin cytoskeleton, we transfected MDCK cells with Vangl24-EGFP, a construct lacking the four amino acids in the PDZ-binding domain (Kallay et al., 2006) . Cells expressing Vangl24-EGFP did not display any aberrant phenotype, indicating that interaction with other proteins via the PDZ-binding domain is essential for Vangl2 to cause the phenotype (Fig. 1M,MЈ) .
Like HEK293T, the MDCK cell line was derived from embryonic kidney, which expresses Vangl2 (Katoh, 2002) . Indeed, MDCK cells also expressed endogenous Vangl2 as shown by RT-PCR (Fig. 1N ). An antibody against Vangl2 yielded weak immunolabeling in the cell membranes (Fig. 1OЈ , arrows), which overlapped with circumferential actin (Fig. 1O ). To investigate loss of Vangl2 function in MDCK cells, we performed RNAi knockdown. Cotransfection with a FITC-labeled oligo was utilized to identify transfected cells. Vangl2 knockdown cells were smaller in size than untransfected (including adjacent) cells (Fig. 1P ,PЈ,PЉ,Q,QЈ). The control cells ordered cortical actin, and intracellular stress fibers were replaced by a diffuse and seemingly unorganized actin distribution. Observe the disorganized appearance of a cluster of cells transfected with Vangl2 RNAi (Fig. 1P ,PЈ,PЉ), and how transfected cells differ from their untransfected neighbors (Fig.  1Q ,QЈ). In areas with many knockdown cells, cell-cell adherence seemed to be compromised (Fig. 1P ,PЈ,PЉ).
We then used HEK293T cells to investigate whether Vangl2 affected the distribution of -catenin and N-cadherin (the cadherin present in HEK293T cells). Control transfected cells displayed a distinct band of cortical -catenin (Fig. 1R) . In Vangl2-transfected cells, this was more disperse and discontinuous (Fig. 1S) . N-cadherin was present in a punctuate band along the cell membrane of control transfected cells (Fig. 1T ). Vangl2 transfection resulted in a more diffuse pattern over the cell membrane and cytoplasm (Fig. 1U) . Endogenous Vangl2 overlapped with N-cadherin in untreated cells (Fig. 1V,VЈ) .
We conclude that both Vangl2 gain-of-function and loss-offunction disturb the localization of actin and actin-associated components of adherens junctions, such as -catenin and Ncadherin, in agreement with previous reports on PCP protein function (Carreira-Barbosa et al., 2003; Darken et al., 2002; Goto and Keller, 2002; Takeuchi et al., 2003; Veeman et al., 2003) . Furthermore, the PDZ-binding domain seems to be essential in mediating this effect.
Vangl2 binds and redistributes Rac1
The effectors of PCP signaling, the GTPases RhoA and Rac1, are key regulators of cadherin-mediated cell-cell adhesion. RhoA regulates the formation of stress fibers and the attachment of cells to the substrate (Nobes and Hall, 1999) . Rac1 has been implicated in controlling adhesion between epithelial cells (Braga et al., 1997; Jou and Nelson, 1998) , and affects adherens junctions (Fischer and Quinlan, 1998; Quinlan, 1999) . We therefore went on to investigate the interaction of Vangl2 with RhoA or Rac1. First, HEK293T cells were transfected as before with control (EGFP) or Vangl2-HA. After 24 hours, Rac1 and RhoA immunolabeling in the control cells appeared as distinct puncta focused to the cell membranes, although
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RhoA labeling was more continuous (Fig. 2A,B ). Vangl2 yielded a more diffuse Rac1 distribution, displaying aggregates of Rac1 puncta associated with both the cell membranes and cytoplasm (Fig.  2C) . The subcellular distribution of RhoA was similar in Vangl2- expressing cells as in control cells, but the labeling intensity was higher (Fig. 2D ). Vangl2 knockdown affected Rac1 distribution similarly to Vangl2 overexpression. Rac1 puncta were distributed throughout the cytoplasm and cell cortex in cells transfected with Vangl2 RNAi (Fig. 2F,H) . By contrast, control transfected cells displayed a distinct Rac1 localization in the cell cortex (Fig. 2E,G) . Co-labeling for Rac1 (Fig. 2I) and Vangl2 (Fig. 2IЈ ) indicated that both Rac1 and endogenous Vangl2 are present in the cell cortex of (Fig. 2N ). By contrast, Vangl2 overexpression did not affect the activation state of Rac1 and RhoA, as demonstrated by pulldown assays with GST-PAK1 or GST-rhotekin, effectors that binds to activated Rac1 or RhoA, respectively (Akasaki et al., 1999; Ren and Schwartz, 2000) ( Fig. 2O ,P). We conclude that Vangl2 can be part of the same protein complex as Rac1 and RhoA, and that the PDZ-binding domain is essential for this, at least in the case of Rac1. Furthermore, Vangl2 affects the subcellular distribution of Rac1.
Rac1 mediates the effects of Vangl2 on the actin cytoskeleton
We then investigated whether the effect of Vangl2 on the actin cytoskeleton was mediated by RhoA or Rac1. HEK293T cells were transfected with control plasmid (DsRed) alone, together with Vangl2-HA, or with plasmids expressing dominant-negative Rac1 (dnRac1N17), dominant-negative RhoA (dnRhoAN19), constitutively active Rac1 (caRac1V12), or constitutively active RhoA (caRhoAV14). HA-Vangl2 was also co-transfected with dnRac1N17, dnRhoAN19, caRac1V12 or caRhoAV14. After 24 or 48 hours, the cells were fixed and the actin cytoskeleton was visualized by FITC-phalloidin. Only experiments with a transfection rate of at least 80% were further analyzed.
Cells transfected by dnRac1N17 grew in monolayers of reduced area, clusters or as single cells (Fig. 3C) , and resembled Vangl2-expressing cells (Fig. 3B ). Cell-cell adherence was apparently reduced compared to control transfected cells (Fig. 3 , compare A,C). Cortical actin was discontinuous, and actin deposits were observed within the cells (arrowheads in Fig. 3C ). Interestingly, co-transfection of dnRac1N17 and Vangl2-HA resulted in a closeto-normal actin distribution (Fig. 3D ). This was not simply due to Vangl2 binding to dnRac1N17 and titrating out its effect, because Vangl2 affected cells treated with Rac1 RNAi similarly. Rac1 RNAi (co-transfected with control vector) had a similar effect as dnRac1N17 transfection (Fig. 3E ). Exchanging control vector for Vangl2-HA reversed the effects of transfection with Rac1 RNAi to a large extent (Fig. 3F) . Transfection of caRac1V12, caRhoAV14 or dnRhoAN19 affected actin distribution and cell shape (Fig. 3G,I ,K). Co-transfection of Vangl2-HA and caRac1V12 accentuated the effects of caRac1V12 alone (Fig. 3H) . On the contrary, no obvious interactions were observed when Vangl2-HA was co-transfected with either caRhoAV14 or dnRhoAN19 (Fig. 3J,L) .
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MDCK cells were then transfected with control plasmid (EGFP) (Fig. 3M,MЈ) , dnRac1N17 (Fig. 2N,NЈ) , or dnRac1N17 in combination with either Vangl2-EGFP (Fig. 3O,OЈ) or Vangl24- EGFP (Fig. 3P,PЈ) . After 36 hours, the cells were fixed and the actin cytoskeleton visualized by TRITC-phalloidin. Transfection rates were relatively low, and EGFP fluorescence was used as a transfection indicator. As was the case with HEK293T cells, MDCK cells transfected with dnRac1N17 (Fig. 3N ,NЈ) differed markedly in their actin distribution compared with control transfected cells (Fig. 3M,MЈ) . Cells co-transfected with dnRac1N17
and Vangl2-EGP were significantly more similar to control transfected cells, or to adjacent, untransfected cells (O,OЈ). Cells co-transfected with dnRac1N17 and Vangl24-EGFP mostly resembled dnRac1N17-transfected cells (Fig. 3P,PЈ) .
In conclusion, Vangl2 overexpression and Rac1 blockade balance each other. The Vangl2 PDZ-binding domain is essential for this to occur. 
Vangl2 affects cell adhesion and migration in interaction with Rac1
To functionally test and quantify the effects of Vangl2 on cell adherence, MDCK cells were transfected with control (DsRed) plasmid; control plasmid combined with Vangl2-HA, dnRac1N17 or caRac1V12; and Vangl2-HA combined with dnRac1N17 or caRac1V12. The cells were then transferred to hanging drop cultures. After 24-48 hours, aggregation was evaluated and quantified as an aggregation index. The higher the index, the higher the ratio of aggregated to single cells (see Materials and Methods) . Control cells displayed a high level of large and middle-sized aggregates, but single cells were also abundant (Fig. 4A) . The aggregation index in Vangl2-expressing cells was 59% of control cells (P0.027, Fig. 4B,G) , indicating that Vangl2 affects cell adherence negatively. dnRac1N17 dramatically reduced the aggregation index (Fig. 4C,G) . However, co-transfection of dnRac1N17 and Vangl2 resulted in a fivefold higher aggregation index (523%, P9ϫ10 -6 ) ( Fig. 4G) , in essence bringing the aggregation index up to the same level as in control cells (Fig. 4D) . caRac1V12 reduced aggregation similarly to dnRac1N17 (Fig. 4E) . Co-transfection with Vangl2 enhanced the effect and slightly further reduced the aggregation index (66% of caRac1V12 alone, P0.022) (Fig. 4F,G) .
In a similar set of experiments with combinations of Vangl2 and dominant negative or constitutive active RhoA, Vangl2 transfection again resulted in a lower level of aggregation (Fig. 4H,I , compare). In this set of experiments, the aggregation index of the Vangl2-treated cells was 42% of control (P0.0077) (Fig. 4N ). Both dnRhoAN19 (Fig. 4J) and caRhoAV14 (Fig. 4L ) reduced the aggregation index (Fig. 4N) . This was not affected by co-transfection with Vangl2-HA (Fig. 4K,M,N) .
In a third set of experiments, we tested the effects of Vangl2 RNAi and Vangl24-EGFP (Fig. 4O-V) . Aggregation in Vangl2-EGFP-treated cells was 60% of control (Fig. 4Q, P0.003) , and in Vangl2-RNAi-treated cells 73% of control (Fig. 4P, P0.011) . Aggregation in Vangl24-EGFP-treated cells was similar to that in control transfected cells (95% of control, Fig. 4T,V) . The difference between Vangl2-EGFP and Vangl24-EGFP treatment was significant (P0.007). Co-transfection of Vangl2-EGFP and dnRac1N17 (Fig. 4S ) restored normal cell aggregation (88% of control), and thus significantly differed from dnRac1N17-treated cells (P0.029). However, cells co-transfected with dnRac1N17 and Vangl24-EGFP (Fig. 4U ) displayed a reduced aggregation (65% of control), which was comparable to that of cells transfected with dnRac1N17 or Vangl2-GFP alone. The difference between Vangl2-GFP + dnRac1N17 and Vangl24-EGFP + dnRac1N17 was significant (P0.016). In sum, these results suggest that Vangl2 gainof-function affects cell adherence in a Rac1-dependent manner, and that the PDZ-binding domain is essential for this.
Reduced cell adherence is often paralleled by increased cellular migration. We thus examined whether Vangl2 affects migratory behavior of C17.2 neural stem cells in wound-healing assays. These cells were chosen because they do not adhere to each other as firmly as HEK293 or MDCK cells, which make it easier to scrape away cells without loosening the entire sheet. Cells were transfected with control plasmid (pcDNA3), Vangl2-HA, dnRac1N17 (combined with control plasmid) or with dnRac1N17 and Vangl2-HA. After 27 hours, a scratch wound was introduced in the cell layer with a pipette tip, and the cells were incubated for 18 hours before the results were evaluated and quantified (see Materials and Methods) . In control cultures, the test area was invaded by low-to-moderate Journal of Cell Science 123 (3) numbers of cells (Fig. 4W,WЈ) . Vangl2-transfected cell cultures displayed 40% higher number of cells (P0.0273) in the test area (Fig. 4X,XЈ) . Co-transfection of Vangl2 and dnRac1N17 blocked this effect (P0.0260, Fig. 4Z,ZЈ) . The observations are quantified in Fig 4AA. We conclude that Vangl2 overexpression can increase cell migration and that this effect can be antagonized by dominantnegative Rac1.
Cranial neurulation is impaired in nestin-Vangl2 embryos
In order to test the effects of Vangl2 overexpression in vivo, a nestinVangl2 construct vector that directs the expression of Vangl2 to neural stem cells was generated as previously described (Shariatmadari et al., 2005) . Transgenic mouse embryos obtained from pronuclear injections of nestin-Vangl2 were analyzed at embryonic day (E) 8.5 and 9.5. Nestin-Vangl2 embryos were identified by PCR and in situ hybridization with a ribo-probe complementary to Vangl2 mRNA (Fig. 5D-F,J-L) . Wild-type E8.5 embryos expressed moderate levels of Vangl2 mRNA in the neural tube, except in the anterior-most and posterior-most sections (Fig.  5D ). At E9.5, Vangl2 mRNA expression was found throughout the neural tube (Fig. 5J) . Nestin-Vangl2 embryos displayed varying expression levels of Vangl2 mRNA. These ranged from a weak general elevation, combined with patches of markedly elevated expression (Fig. 5E,K) , to a highly elevated Vangl2 overexpression throughout the neural tube and/or plate except at the lateral-most edges (Fig. 5F,L) . Mildly affected E8.5 nestin-Vangl2 transgenic embryos were similar or somewhat smaller in size than wild-type littermates (Fig.  5A,B, compare) . Their neural folds were more splayed out, and they appeared to have less rigid bodies than wild-type embryos (Fig.  5A ,B, compare with 5D,E). Severely affected E8.5 embryos were smaller in size and had less rigid bodies than wild-type embryos (Fig. 5C) . Neural tube closure, particularly in the cranial compartment, was impaired, with the neural folds displaying little or no elevation (Fig. 5F ). Nestin-Vangl2 embryos investigated at E9.5 were smaller than their wild-type littermates. Wild-type littermates had completed cranial neural tube closure (Fig. 5G) , but nestin-Vangl2 embryos still displayed open cranial neural folds (Fig.  5H,I ). We conclude that the nestin-Vangl2 embryos display an impaired cranial neurulation, a phenotype similar to that of nestinWnt7a transgenic embryos. This is in line with the effects of Wnt7a being partly mediated by Vangl2, as we have suggested previously (Shariatmadari et al., 2005) .
Cytoskeletal components of adherens junctions are misdistributed in nestin-Vangl2 embryos
The distribution of actin microfilaments in transversal sections of neural tubes from E8.5 and E9.5 embryos was investigated using FITC-labeled phalloidin. In wild-type embryos (n3 each age group), actin microfibers were present as weak circumferential rings in the cortex of each cell (Fig. 6A,E, enlarged in B,F) . The apical ends of the neural tube cells, facing the lumen, displayed clear actin enrichment, indicative of adherens junctions. These could be identified as ring-like structures in more oblique cut fields of the sections (arrow in Fig. 6B,F) . The neural tube cells of the nestinVangl2 embryos (n3 each age group) displayed more diffuse cortical actin than their wild-type littermates (Fig. 6C ,G, enlarged in D,H). Actin enrichment over the adherens junctions was absent or very low. In the cases in which actin enrichment was observed, actin was present in fragmentary patches (Fig. 6D,H, arrowheads) . Furthermore, the typical ring-like structures of adherens junctions were not observed.
The distribution of -catenin and N-cadherin in wild-type embryos (n2 each age group) overlapped with that of actin, as expected (Fig. 6I,M, enlarged in J,N) . In nestin-Vangl2 embryos (n2 each age group), enrichment over the adherens junctions was absent or very low, similar to that observed for actin, suggesting a functional impairment of the adherens junctions (Fig. 6K,O , enlarged in L,P). This was further supported by observations of the neural tube luminal wall: in wild-type embryos it is smooth, but in nestin-Vangl2 transgenic embryos it is irregular, with groups of cells protruding into the lumen (Fig. 6C,D,G, arrows) . Individual cells also appeared more rounded in the transgenic than in the control embryos, suggesting a defect in cell-cell adherence (compare cell shapes in Fig. 6L ,P with 6J,N). The embryos thus resembled a previously described telencephalic -catenin knockout (Junghans et al., 2005) .
The cellular distribution of Rac1 is altered in the nestinVangl2 embryos
Rac1 immunolabeling was detected over the adherens junctions in neural tubes of wild-type E8.5 (n4) and E9.5 (n4) embryos (Fig.  7A,B, arrows) . In addition, the E8.5 embryos frequently displayed strong nuclear and/or cytoplasmic Rac1 labeling, mostly in cell soma adjacent to the lumen (Fig. 7A, small arrows) . E8.5 nestin-Vangl2 (n4) embryos displayed prominent nuclear and/or cytoplasmic Rac1 labeling in cell soma scattered over the neural tube. Labeling over the adherens junctions was reduced, displayed paucity or was completely absent (Fig. 7C, arrowhead) . E9.5 nestin-Vangl2 embryos (n4) displayed a reduced level of Rac1 labeling over the adherens junctions (Fig. 7D, arrowhead) . Apart from the adherens junctions, wild-type embryos displayed distinct Rac1 labeling at the neural tube cell membranes. In nestin-Vangl2 embryos, labeling of the neural tube cells was more diffuse (compare Fig. 7B and 7D ).
Vangl2 loss-of-function in the neural tube is correlated with an impaired cytoskeleton
The effects of Vangl2 loss-of-function was studied in loop-tail (lp -/-) mouse embryos, which are homozygous for a Vangl2 loss-of- function mutation (Kibar et al., 2001; Murdoch et al., 2001a) . Wildtype mice express Vangl2 throughout the neural tube from E7.5 and onwards (Torban et al., 2007) .
First, we compared the distribution of cytoskeletal components in transversal sections of neural tubes from E9.5 wild-type (lp +/+ ), lp +/-(n2) and lp -/-(n2) embryos. FITC-phalloidin labeling of actin was similar in wild-type and lp +/-embryos, and so lp +/-embryos were therefore used as controls. Actin staining in control embryos was as described above. Oblique cut sections with the ringlike adherens junctions apparent were frequently observed (Fig.  8A,B) . The most rostral sections of lp -/-neural tubes displayed a normal actin distribution. In sections from hindbrain and caudally we observed lower actin levels over the adherens junctions than in control embryos (Fig. 8C,D,K, compare with 8A,B,I ). Phalloidin staining was uneven or punctuate (Fig. 8D) . Other cytoskeletal components associated with adherens junctions (-catenin, Ncadherin, and p120-catenin) displayed a similar distribution as actin, with a clear enrichment in control embryos (Fig. 8E,F,M) . In lp -/-embryos, enrichment of these cytoskeletal components over the adherens junctions was less prominent, or absent, in the caudo-lateral parts of the neural tube (Fig. 8G,H,O) .
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The loop-tail embryos complete cranial neurulation, but the neural tube remains open from the hindbrain and further caudally. The observed effects on the adherens junctions correlated with this, with no aberrances rostral of the hindbrain. Caudal of this, adherens junctions displayed aberrant distribution of cytoskeletal components. Ring-like adherens junctions were observed in the rostral part of the lp -/-embryos, but not in any of the caudo-lateral sections (Fig.  8C,D,G,H,K,O) . Moreover, cells in the lp -/-neural tubes tended to be less orderly arranged, and displayed a more rounded shape than those of controls (particularly evident in Fig. 8G,H) .
The distribution of Rac1 was altered in loop-tail embryos
Rac1 immunolabeling was similar in wild-type and lp +/-embryos as expected (Fig. 8J) . The distribution of Rac1 was normal in sections of lp -/-embryos rostral of the hindbrain. More caudolaterally intense Rac1 labeling was observed in the cytoplasm of cells adjacent to the adherens junctions, suggesting that the distinct Rac1 localization was lost (Fig. 8L) . Like in nestin-Vangl2 embryos, Rac1 labeling in lp -/-mutants was more dispersed across the neural tube (compare with Fig. 7 ). Immunolabeling with a second Rac1 antibody yielded a similar diffuse labeling in lp -/-mutants (data not shown). In contrast to Rac1, the distribution of RhoA was unaltered in lp -/-embryos ( Fig. 8N,P) . In summary, with the exception of the rostral-most neural tube, distribution of cytoskeletal components and Rac1 was altered over the adherens junctions of E9.5 lp -/-embryos. This complements our gain-of-function data and demonstrates that Vangl2 is required for the adherens junctions formation in vivo.
Discussion
Vangl2 is an essential component of the Wnt/PCP pathway, which acts via activation of the GTPases RhoA and Rac1 (Habas et al., 2003) . Here, we used gain-of-function and loss-of-function approaches, both in vitro and in vivo, to demonstrate that Vangl2 affects the cytoskeleton and cell adhesion via Rac1.
Both decreases and increases in Vangl2 levels resulted in aberrant distribution of actin and other cytoskeletal components. Vangl2 is a transmembrane protein and ectopically expressed Vangl2 was located to the cell membrane, but also to the cytoplasmic compartment (Fig. 1BЈ,HЈ,IЈ) , where we also observed increased levels of Rac1 granules. Furthermore, Vangl2 knockdown resulted in a diffuse Rac1 labeling over the cytoplasm (Fig. 2F,H) . Immunoprecipitation demonstrated that Vangl2 is present in complex with Rac1 and RhoA (Fig. 2L,M,N) , and that the PDZbinding domain of Vangl2 is essential for this (Fig. 2N) . However, the overall levels of Rac1 and Rac1 activation were not affected by Vangl2 (Fig. 2O,P) . On the basis of these observations, we propose a model in which Vangl2 does not affect Rac1 activity directly, but recruits Rac1 to locally increase its concentration at the membrane or other cellular compartments.
We suggest that Vangl2, which is located at adherens junctions (Fig. 1OЈ) , is required for the proper recruitment of Rac1 to the adherens junction. Active Rac1 is known to promote actin polymerization at the cell periphery (Hall and Nobes, 2000) . The crucial function of Rac1 in the actin cytoskeleton and cell adherence has been demonstrated previously (Jou and Nelson, 1998) , and is also confirmed in our experiments with RNAi knockdown of endogenous Rac1 or dominant-negative Rac1. Importantly, previous studies have demonstrated that the actin cytoskeleton is disrupted both by increased and decreased Rac1 signaling (Jou and Nelson, 1998) . In line with these findings, we demonstrate that both Vangl2 loss-of-function and gain-of-function result in disruption of the cytoskeleton and decreased cell adherence. Furthermore, our rescue experiments support an interaction between Vangl2 and Rac1. dnRac1N17 is believed to inhibit endogenous Rac1 by competitive inhibition (Coso et al., 1995; Feig and Cooper, 1988) , and dnRac1 is thus functionally identical to Rac1 knockdown. Both these conditions disrupt the actin cytoskeleton (Fig. 3C,E,N) and cause adhesion defects (Fig. 4B,I ,P,Q). These alterations were rescued by simultaneous Vangl2 overexpression, resulting in an almost normal actin distribution (Fig. 3D,F ,O) and cell adherence (Fig. 4D,S) . We suggest that Vangl2 overexpression balances the effects of dominantnegative Rac1 or RNAi knockdown by increased recruitment of endogenous Rac1, thus restoring Rac1 levels locally in the cell cortex. This is further supported by our finding that overexpression of Vangl24-GFP affects neither the actin cytoskeleton (Fig. 1M ) nor cell adherence (Fig. 4T) . The Vangl24-GFP mutant lacks the PDZ-binding domain, and immunoprecipitation experiments demonstrate that it is incapable of binding Rac1 (Fig. 2N ). In line with this, Vangl24-GFP fails to rescue the actin cytoskeleton ( Fig.  3P ) and cell adherence (Fig. 4U ) from the effects of dnRac1N17. However, the exact mode of interaction between Vangl2 and Rac1 remains to be elucidated. Other molecules might be involved, for example Scrib, which can bind Vangl2 via its PDZ-binding domain (Kallay et al., 2006) .
Many molecules can contribute to membrane localization of Rac1 (Williams, 2003) . However, we demonstrate that Vangl2 is present in HEK293T and MDCK cells (Fig. 1E,N) , and that Vangl2 knockdown disrupts the actin cytoskeleton ( Fig. 1F,P) . Furthermore, Vangl2 is known to be expressed in the neural tube cells of wildtype mouse embryos. We suggest that Vangl2 in the neural tube contributes to maintenance of the actin cytoskeleton via Rac1, because Vangl2 loss of function in the lp -/-mutant is correlated with actin filament collapse (Fig. 8C,D) and altered Rac1 distribution (Fig. 8L ) in the caudal neural tube. However, the mislocalization of Rac1 could also be secondary to altered cell polarity. More rostral sections of the neural tube in lp -/-mutants displayed normal adherens junctions. This is not surprising because cranial neurulation, which depends on the integrity of adherens junctions (Ybot-Gonzalez and Copp, 1999) , proceeds normally in the lp -/-embryos. Instead, the lp -/-embryos display craniorachischisis, a failure to close the neural tube from the hindbrain and caudally. This phenotype is a consequence of an impaired convergent extension (Darken et al., 2002; Goto and Keller, 2002) . Interestingly, it has been suggested that Vangl2 influences convergent extension via regulation of cell adhesion (Ciruna et al., 2006) .
In conclusion, we demonstrate that Vangl2 affects the cytoskeleton and cell adhesion in epithelial cell lines and in the embryonic neural plate and/or tube. Moreover, we identify the small GTPase Rac1 as a key player in this process. Importantly, both a defective recruitment (Rac1 and/or Vangl2 loss-of-function) and an excessive recruitment (Rac1 and/or Vangl2 gain-of-function) lead to cytoskeletal abnormalities and impaired adhesion. Although further studies are needed to elucidate this mechanism on a structural level, our results indicate that the precise regulation of Vangl2 levels and its interaction with Rac1 is of key importance for the appropriate regulation of cell adhesion and neural tube development.
Materials and Methods
Generation of the Vangl2-HA and nestin-Vangl2 constructs.
A 1566-bp fragment spanning the open reading frame of Vangl2 and flanked by XhoI and HindIII sites was generated by PCR from a cDNA clone containing the Vangl2 coding sequence [I.M.A.G.E. Consortium (LLNL) cDNA CloneID 6509008 (Lennon et al., 1996) ] purchased from RZPD (www.rzpd.de; RZPD CloneID IMAGp998J1714075Q3). It was then inserted into the XhoI and/or HindIII site of the pcDNA3-HA expression vector or the NotI site of the human nestin (hnestin) 1852 vector (Lothian and Lendahl, 1997; Shariatmadari et al., 2005) . The (human) Vangl2-EGFP and Vangl2D4-EGFP constructs were kind gifts from Lelita T. Braiterman (Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD) (Kallay et al., 2006) .
Cell cultures and transfection experiments
HEK293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, cat no. 11971) supplemented with 10% fetal bovine serum (FBS) and antibiotics; MDCK cells in MEM (GIBCO, cat. no. 21090) supplemented with 10% FBS, 2 mM L-glutamine, 1% non-essential amino acids, and antibiotics; and C17.2 cells in DMEM (GIBCO, cat. no. 41966) supplemented with 10% FBS, 5% horse serum, 2 mM L-glutamine and antibiotics (all supplements from GIBCO). HEK293T and MDCK cells were kindly provided by Anita Aperia (Department of Woman and Child Health, Karolinska Institutet), and C17.2 cells by Eric Herlenius (Department of Woman and Child Health, Karolinska Institutet). RNAi hairpins (Stealth siRNA duplex oligoribonucleotides) complementary to human Rac1 and Vangl2 mRNAs were designed by Invitrogen. Cells were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
Immunocytochemistry
HEK293T, MDCK or C17.2 cells were fixed with 4% paraformaldehyde, permeabilized and blocked in 7% non-fat dry milk and 0.1% Triton X-100 in PBS. Primary antibodies were incubated at 4°C overnight, then rinsed three times in PBS. Secondary antibodies were diluted in PBS. Primary antibodies: anti--catenin (BD Biosciences, San Jose, CA) at 1:200 dilution; anti-N-cadherin at 1:100 dilution, antiRac1 at 1:200 dilution, anti-RhoA at 1:50 dilution (all from Santa Cruz Biotechnology, Santa Cruz, CA); anti-p120 catenin at 1:100 dilution (BD Biosciences, Franklin Lakes, NJ); anti-Vangl2 (R&D Systems); and anti-HA (Sigma-Aldrich, St Louis, MO) at 1:300 dilution. Endogenous actin was visualized with FITC-or TRITC-phalloidin (Sigma-Aldrich) diluted to 50 g/ml in PBS.
Actin rating
Actin distribution in HEK293T and MDCK cells was blindly rated by three observers. For HEK293T cells, cortical actin, intracellular actin and general cell shape were given a score of 0-3. A high score indicated a high aberration from a hypothetical normal appearance. The three ratings for each cell were summed, and 1 was added, yielding a cell score of between 1 and 10. The ratings were averaged, and a t-test performed. For MDCK cells, the observers individually rated cortical actin, stress fibers and cell shape in comparison to the adjacent, non-transfected cells. The results were then treated similarly to results for the HEK293T cells.
Aggregation assay
MDCK cells were cultured until 70% confluency and then transfected using Lipofectamine 2000. After 4 hours, the cells were scraped off the culture dishes, washed in new medium, counted and transferred in drops of 30 l (1000 cells/l) to the inside of a 24-well plate-lid. With PBS in the bottom of the wells, the hanging drops were incubated for 24-48 hours. The drops were then pipetted up and down 10 times with a 200 l tip and analyzed in a light microscope. For quantification, representative micrographs from a single experiment were used. Quantification of the first two sets of experiments (Fig. 4G,N) was performed as follows: The pictures were overlaid with a 48-square grid. For each picture, the number of squares containing aggregates with at least four cells was divided by the number of squares containing only single cells or aggregates with less than four cells. This yielded an aggregation index. The aggregation indexes from four micrographs per experimental condition were averaged and used for comparison. A standard t-test was performed. For the third set of aggregation assays a modified method was employed because the cell density was higher in all experimental conditions. The micrographs were overlaid with an 80-square grid. Only squares containing cell aggregates with four or more cells that stretched into a neighboring square were counted. The data were then treated similarly to treatment in the first two experimental sets.
Wound assay
Subconfluent C17.2 cells were transfected as above and then allowed to reach 100% confluency. The cells were then treated with 10 M mitomycin C (Sigma-Aldrich) for 3 hours to arrest the cell cycle. A wound was made through the cells using a 200 l pipette tip. Medium was changed to serum-reduced (1% FBS) to keep the cells from dividing, and a line was drawn underneath the culture dish perpendicular to the scratch. Pictures were taken just above or below the line under a light phase-contrast microscope, immediately and after 18 hours. For quantification of the results, a representative area was chosen in micrographs taken at 0 hours, and the distance between the edges of the wound were measured. The same area in the micrographs was identified after 18 hours. The measured distance was used as a baseline which, combined with a fixed height, yielded a rectangular field. The number of cells within the field was calculated and then divided by the area.
Immunoprecipitation
Cells grown on a 10-cm culture dish were extracted for 15 minutes in ice-cold lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM sodium chloride, 0.1% SDS, 1 mM EDTA, 1ϫ Roche protease inhibitor cocktail). Then, extracts were cleared by centrifugation at 15,000 g for 5 minutes at 4°C and stored at -80°C until use. The extracts were incubated with anti-HA (Abcam), anti-Rac1 (Upstate) or anti-RhoA (Santa Cruz Biotechnology) antibody for 1 hour in an ice bath. Immunoprecipitates were collected on Protein G Sepharose Fast Flow beads (Amersham Biosciences) by overnight rotation, washed four times with lysis buffer and resuspended in 2ϫ Laemmli sample buffer. Samples were then subjected to SDS-PAGE followed by western blot analysis using anti-HA (Abcam), anti-Vangl2 (R&D Systems), anti-Rac1 (Upstate) or antiRhoA (Santa Cruz Biotechnology) antibodies. Western blotting was performed as described previously (Bryja et al., 2007) .
Pull-down assay
Glutathione-S-transferase (GST)-p21-activated kinase (PAK)-Cdc42/Rac interactive binding domain (CRIB), and GST-RHOtekin recombinant proteins coupled to Sepharose beads were prepared as described previously (Edlund et al., 2002) . GST-PAK-CRIB, and GST-RHOtekin pull-down assays for detection of activated Rac1 and RhoA, respectively, were performed as follows: Cells were washed with icecold PBS and subsequently allowed to lyse in ice-cold lysis buffer (10 mM TrisHCl pH 7.5, 110 mM NaCl, 1 mM EDTA, 10 mM MgCl 2 , 1% Triton X-100, 0.1% SDS, 20 mM -glycerolphosphate, 1 mM dithiotreitol, complete protease inhibitors) for 5 minutes. Crude cell lysates were spun down in prechilled tubes at 16,000 g for 5 minutes at 4°C. Supernatants (5% saved as input) were supplemented with bait proteins coupled to GST beads, and tubes were incubated rotating end-overend at 4°C for 15 minutes. Beads were washed three times with washing buffer (lysis buffer without SDS and protease inhibitors) on ice and subsequently mixed with 2ϫ Laemmli buffer. Each sample was boiled for 5 minutes before loading on SDS-PAGE.
Vangl2 RT-PCR in HEK293T and MDCK cells
Vangl2 gene expression was investigated by real-time RT-PCR (iQ5 Real-Time Detection System, Bio-Rad Laboratories, Sundbyberg, Sweden) in control transfected and Vangl2-overexpressing cells. The iScript One-Step RT-PCR kit (Bio-Rad) with SYBR green was utilized for the reactions according to the manufacturer's instructions. All reactions were performed both with and without added reverse transcriptase. The end product was run on a 2% agarose gel.
Identification of transgenic, loop-tail embryos and in situ hybridization
The expression cassette, hnestin 1852/tk promoter Vangl2 ORF was used for pronuclear injection of fertilized mouse oocytes. Oocytes were used to generate transgenic mice using standard techniques. Pregnant dams with embryos of E8.5 or E9.5 were sacrificed by spinal dislocation, and the embryos were rapidly dissected out. Yolk sac DNA was used to genotype transgenic and loop-tail embryos. PCR to identify transgenics was performed with a sense primer complementary to human nestin intron 2 combined with an antisense primer complementary to the Vangl2 ORF. Loop-tail embryos were identified by PCR performed with primers against a microsatellite sequence for the lpt locus. Vangl2 mRNA expression was investigated by digoxigenin in situ hybridization. A standard protocol from the manufacturer (Roche) was used with some modifications. The riboprobe template was generated by PCR from the Vangl2 CDS (16-455 bp). Animals were treated according to European Communities Council Guidelines (Directive 86/609/EEC).
Immunohistochemistry
Immunohistochemistry was performed as previously described (Shariatmadari et al., 2005) . Primary antibodies used were anti--catenin (BD Biosciences) at a 1:200 dilution, anti-N-cadherin at a 1:100 dilution, anti-Rac1 at a 1:200 dilution, anti-Scrb1 at a 1:50 dilution (all from Santa Cruz Biotechnology) and anti-Rac1 (Upstate) at a 1:100 dilution.
